
A better pill to swallow: the bid to end AIDS
Economist Podcasts
00:00
Investing in HIV Treatments: Cost-Effectiveness and Public Health
This chapter examines the financial challenges of developing new HIV treatments, focusing on the importance of negotiating drug prices. It argues that investing in prevention and innovative therapies can lead to significant long-term savings and better health outcomes in low- and middle-income countries.
Transcript
Play full episode